These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 27043540)
1. pH-Responsive Hyaluronic Acid-Based Mixed Micelles for the Hepatoma-Targeting Delivery of Doxorubicin. Wu JL; Tian GX; Yu WJ; Jia GT; Sun TY; Gao ZQ Int J Mol Sci; 2016 Mar; 17(4):364. PubMed ID: 27043540 [TBL] [Abstract][Full Text] [Related]
2. Liver-Targeting and pH-Sensitive Sulfated Hyaluronic Acid Mixed Micelles for Hepatoma Therapy. Li ZP; Tian GX; Jiang H; Pan RY; Lian B; Wang M; Gao ZQ; Zhang B; Wu JL Int J Nanomedicine; 2019; 14():9437-9452. PubMed ID: 31819442 [TBL] [Abstract][Full Text] [Related]
3. Nanomicelles based on a boronate ester-linked diblock copolymer as the carrier of doxorubicin with enhanced cellular uptake. Xu Y; Lu Y; Wang L; Lu W; Huang J; Muir B; Yu J Colloids Surf B Biointerfaces; 2016 May; 141():318-326. PubMed ID: 26874117 [TBL] [Abstract][Full Text] [Related]
4. Reduction-sensitive CD44 receptor-targeted hyaluronic acid derivative micelles for doxorubicin delivery. Yang Y; Zhao Y; Lan J; Kang Y; Zhang T; Ding Y; Zhang X; Lu L Int J Nanomedicine; 2018; 13():4361-4378. PubMed ID: 30100720 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular carcinoma dually-targeted nanoparticles for reduction triggered intracellular delivery of doxorubicin. Mezghrani O; Tang Y; Ke X; Chen Y; Hu D; Tu J; Zhao L; Bourkaib N Int J Pharm; 2015 Jan; 478(2):553-68. PubMed ID: 25455765 [TBL] [Abstract][Full Text] [Related]
6. Self-assembled pH-responsive hyaluronic acid-g-poly((L)-histidine) copolymer micelles for targeted intracellular delivery of doxorubicin. Qiu L; Li Z; Qiao M; Long M; Wang M; Zhang X; Tian C; Chen D Acta Biomater; 2014 May; 10(5):2024-35. PubMed ID: 24365705 [TBL] [Abstract][Full Text] [Related]
7. pH- and GSH-Sensitive Hyaluronic Acid-MP Conjugate Micelles for Intracellular Delivery of Doxorubicin to Colon Cancer Cells and Cancer Stem Cells. Debele TA; Yu LY; Yang CS; Shen YA; Lo CL Biomacromolecules; 2018 Sep; 19(9):3725-3737. PubMed ID: 30044910 [TBL] [Abstract][Full Text] [Related]
8. A54 Peptide Modified and Redox-Responsive Glucolipid Conjugate Micelles for Intracellular Delivery of Doxorubicin in Hepatocarcinoma Therapy. Liu N; Tan Y; Hu Y; Meng T; Wen L; Liu J; Cheng B; Yuan H; Huang X; Hu F ACS Appl Mater Interfaces; 2016 Dec; 8(48):33148-33156. PubMed ID: 27934140 [TBL] [Abstract][Full Text] [Related]
9. Coordinated pH/redox dual-sensitive and hepatoma-targeted multifunctional polymeric micelle system for stimuli-triggered doxorubicin release: Synthesis, characterization and in vitro evaluation. Wang L; Tian B; Zhang J; Li K; Liang Y; Sun Y; Ding Y; Han J Int J Pharm; 2016 Mar; 501(1-2):221-35. PubMed ID: 26851356 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy. Shao Y; Luo W; Guo Q; Li X; Zhang Q; Li J Drug Des Devel Ther; 2019; 13():2043-2055. PubMed ID: 31388296 [No Abstract] [Full Text] [Related]
11. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
12. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
13. MRI-visible and pH-sensitive micelles loaded with doxorubicin for hepatoma treatment. Li B; Cai M; Lin L; Sun W; Zhou Z; Wang S; Wang Y; Zhu K; Shuai X Biomater Sci; 2019 Mar; 7(4):1529-1542. PubMed ID: 30681081 [TBL] [Abstract][Full Text] [Related]
14. Acid and reduction stimulated logic "and"-type combinational release mode achieved in DOX-loaded superparamagnetic nanogel. Song M; Xue Y; Chen L; Xia X; Zhou Y; Liu L; Yu B; Long S; Huang S; Yu F Mater Sci Eng C Mater Biol Appl; 2016 Aug; 65():354-63. PubMed ID: 27157762 [TBL] [Abstract][Full Text] [Related]
15. Doxorubicin loaded pH-sensitive micelle targeting acidic extracellular pH of human ovarian A2780 tumor in mice. Gao ZG; Lee DH; Kim DI; Bae YH J Drug Target; 2005 Aug; 13(7):391-7. PubMed ID: 16308207 [TBL] [Abstract][Full Text] [Related]
16. Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid. Wang X; Gu X; Wang H; Yang J; Mao S Carbohydr Polym; 2018 Sep; 195():170-179. PubMed ID: 29804965 [TBL] [Abstract][Full Text] [Related]
17. Doxorubicin loaded pH-sensitive micelle: antitumoral efficacy against ovarian A2780/DOXR tumor. Kim D; Lee ES; Park K; Kwon IC; Bae YH Pharm Res; 2008 Sep; 25(9):2074-82. PubMed ID: 18449626 [TBL] [Abstract][Full Text] [Related]
18. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of doxorubicin and (131)I by thermosensitive micellar-hydrogel for enhanced in situ synergetic chemoradiotherapy. Huang P; Zhang Y; Wang W; Zhou J; Sun Y; Liu J; Kong D; Liu J; Dong A J Control Release; 2015 Dec; 220(Pt A):456-464. PubMed ID: 26562684 [TBL] [Abstract][Full Text] [Related]
20. Free Adriamycin-Loaded pH/Reduction Dual-Responsive Hyaluronic Acid-Adriamycin Prodrug Micelles for Efficient Cancer Therapy. Yin T; Wang Y; Chu X; Fu Y; Wang L; Zhou J; Tang X; Liu J; Huo M ACS Appl Mater Interfaces; 2018 Oct; 10(42):35693-35704. PubMed ID: 30259743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]